222 related articles for article (PubMed ID: 34669428)
21. VP2 gene based phylogenetic relationship of Indian isolates of Bluetongue virus serotype 1 and other serotypes from different parts of the world.
Dahiya S; Prasad G; Kovi RC
DNA Seq; 2004; 15(5-6):351-61. PubMed ID: 15621660
[TBL] [Abstract][Full Text] [Related]
22. Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway.
Kundlacz C; Pourcelot M; Fablet A; Amaral Da Silva Moraes R; Léger T; Morlet B; Viarouge C; Sailleau C; Turpaud M; Gorlier A; Breard E; Lecollinet S; van Rijn PA; Zientara S; Vitour D; Caignard G
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167915
[TBL] [Abstract][Full Text] [Related]
23. Computer-Aided Structure Prediction of Bluetongue Virus Coat Protein VP2 Assisted by Optimized Potential for Liquid Simulations (OPLS).
Prajapati L; Khandelwal R; Yogalakshmi KN; Munshi A; Nayarisseri A
Curr Top Med Chem; 2020; 20(19):1720-1732. PubMed ID: 32416694
[TBL] [Abstract][Full Text] [Related]
24. VP2-segment sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean basin during the 1998-2003 outbreak.
Potgieter AC; Monaco F; Mangana O; Nomikou K; Yadin H; Savini G
J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(9):372-9. PubMed ID: 16283915
[TBL] [Abstract][Full Text] [Related]
25. Entry of Bluetongue Virus Capsid Requires the Late Endosome-specific Lipid Lysobisphosphatidic Acid.
Patel A; Mohl BP; Roy P
J Biol Chem; 2016 Jun; 291(23):12408-19. PubMed ID: 27036941
[TBL] [Abstract][Full Text] [Related]
26. Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication.
Roy P
Cell Biochem Biophys; 2008; 50(3):143-57. PubMed ID: 18299997
[TBL] [Abstract][Full Text] [Related]
27. Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus.
van Gennip RGP; Drolet BS; Rozo Lopez P; Roost AJC; Boonstra J; van Rijn PA
Parasit Vectors; 2019 Oct; 12(1):470. PubMed ID: 31604476
[TBL] [Abstract][Full Text] [Related]
28. Structural Basis and Evolution of Glycan Receptor Specificities within the Polyomavirus Family.
Ströh LJ; Rustmeier NH; Blaum BS; Botsch J; Rößler P; Wedekink F; Lipkin WI; Mishra N; Stehle T
mBio; 2020 Jul; 11(4):. PubMed ID: 32723915
[TBL] [Abstract][Full Text] [Related]
29. Development of a Double-Antigen Microsphere Immunoassay for Simultaneous Group and Serotype Detection of Bluetongue Virus Antibodies.
Breard E; Garnier A; Despres P; Blaise Boisseau S; Comtet L; Viarouge C; Bakkali-Kassimi L; Pourquier P; Hudelet P; Vitour D; Rossi S; Belbis G; Sailleau C; Zientara S
Transbound Emerg Dis; 2017 Dec; 64(6):1837-1847. PubMed ID: 27667484
[TBL] [Abstract][Full Text] [Related]
30. Expression of the outer capsid protein, VP2, from a full length cDNA clone of genome segment 2 of bluetongue serotype 1 from South Africa, using both Sp6 and vaccinia expression systems and a comparison of the nucleic acid sequence of this segment with those of other serotypes.
Wade-Evans AM; Mertens PP
Virus Res; 1990 Mar; 15(3):213-29. PubMed ID: 2160764
[TBL] [Abstract][Full Text] [Related]
31. A quantitative real-time reverse transcription PCR (qRT-PCR) assay to detect genome segment 9 of all 26 bluetongue virus serotypes.
Maan NS; Maan S; Belaganahalli M; Pullinger G; Montes AJ; Gasparini MR; Guimera M; Nomikou K; Mertens PP
J Virol Methods; 2015 Mar; 213():118-26. PubMed ID: 25486080
[TBL] [Abstract][Full Text] [Related]
32. Restriction analysis of conserved and variable regions of VP2 gene of Indian isolates of bluetongue virus serotype 1.
Dahiya S; Prasad G; Minakshi ; Kovi RC
Indian J Exp Biol; 2005 Mar; 43(3):272-6. PubMed ID: 15816416
[TBL] [Abstract][Full Text] [Related]
33. Structure analysis of the major capsid proteins of human polyomaviruses 6 and 7 reveals an obstructed sialic acid binding site.
Ströh LJ; Neu U; Blaum BS; Buch MH; Garcea RL; Stehle T
J Virol; 2014 Sep; 88(18):10831-9. PubMed ID: 25008942
[TBL] [Abstract][Full Text] [Related]
34. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
Feenstra F; van Gennip RGP; Maris-Veldhuis M; Verheij E; van Rijn PA
J Gen Virol; 2014 Sep; 95(Pt 9):2019-2029. PubMed ID: 24914064
[TBL] [Abstract][Full Text] [Related]
35. Bluetongue virus entry into cells.
Forzan M; Marsh M; Roy P
J Virol; 2007 May; 81(9):4819-27. PubMed ID: 17267479
[TBL] [Abstract][Full Text] [Related]
36. Bluetongue virus: virology, pathogenesis and immunity.
Schwartz-Cornil I; Mertens PP; Contreras V; Hemati B; Pascale F; Bréard E; Mellor PS; MacLachlan NJ; Zientara S
Vet Res; 2008; 39(5):46. PubMed ID: 18495078
[TBL] [Abstract][Full Text] [Related]
37. Virus and host factors affecting the clinical outcome of bluetongue virus infection.
Caporale M; Di Gialleonorado L; Janowicz A; Wilkie G; Shaw A; Savini G; Van Rijn PA; Mertens P; Di Ventura M; Palmarini M
J Virol; 2014 Sep; 88(18):10399-411. PubMed ID: 24991012
[TBL] [Abstract][Full Text] [Related]
38. A viral nonstructural protein regulates bluetongue virus trafficking and release.
Celma CC; Roy P
J Virol; 2009 Jul; 83(13):6806-16. PubMed ID: 19369335
[TBL] [Abstract][Full Text] [Related]
39. Bluetongue virus serotype 17 sequence variation associated with neutralization.
Wilson WC; Bernard KA; Israel BA; Mecham JO
DNA Seq; 2008 Jun; 19(3):237-40. PubMed ID: 17852347
[TBL] [Abstract][Full Text] [Related]
40. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
Mokoena NB; Moetlhoa B; Rutkowska DA; Mamputha S; Dibakwane VS; Tsekoa TL; O'Kennedy MM
Vaccine; 2019 Sep; 37(41):6068-6075. PubMed ID: 31471154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
